CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,562 followers.

CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy https://t.co/S9j6TEFw75 https://t.co/qFI6qe3ohe

28 Oct 2022

Reply Repost Favourite

New Research: CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy: Rationale Recent studies have demonstrated the feasibility of CD38-specific antibody constructs for in vivo imaging of multiple… https://t.co/6chPS

27 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.